[Clinical experiences with betahistine].
50 patients with disorders of the cochleo-vestibular system due a wide variety of causes were treated with Betahistine (Betaserc). The reaction of Betaserc was different in vertigo, tinnitus and hearing loss. As expected, the result of the treatment depends on kind and duration of the disease. Best results were found for M. Ménière. Summarizing Betaserc can be said to be most effective in treating vertigo, less effective in treating tinnitus, but inappropriate in treating hearing loss.
D000328:Adult; D000368:Aged; D001621:Betahistine / Q000627:therapeutic use*; D003051:Cochlea; D005260:Female; D034381:Hearing Loss / Q000188:drug therapy; D006801:Humans; D007759:Labyrinth Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use*; D014012:Tinnitus / Q000188:drug therapy; D014717:Vertigo / Q000188:drug therapy; D014722:Vestibule, Labyrinth
D011725:Pyridines; D001621:Betahistine
Klinische erfahrungen mit betahistin.